To our knowledge, this study investigated the first time gene mutation type distribution in Chinese CRC population, and involved not only KRAS, but also BRAF, PIK3CA, NRAS together for comprehensive analysis between gene mutation and clinicopathological characteristics, in addition, the overall survival of metastatic colorectal cancer. This evidence concerns the gene KRAS and metastatic colorectal cancer.